MA05.07 Efficacy and Safety of Re-Treatment with Tremelimumab and Durvalumab Within the NIBIT-MESO-1 Study
JOURNAL OF THORACIC ONCOLOGY(2019)
关键词
Immune Checkpoint Inhibitors,NIBIT-MESO-1,Mesothelioma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要